Scientific publications

Response of resistant melanoma to a combination of weekly paclitaxel and bevacizumab

M. González Cao, S. Viteri, C. Garrán, Y. Nieto, J. Aristu [SP], M. Ponz [SP] and S. Martín Algarra
Oncology Department, Clínica Universitaria de Navarra, Pamplona, Spain

Magazine: Clinical and Translational Oncology

Date: Feb 1, 2007

Radiation Oncology Medical Oncology

We report here a taxol–bevacizumab-responsive metastatic melanoma case.

Although the patient had been heavily pretreated for two years, she did not show any stabilisation or objective response of her disease. After treatment with taxol and bevacizumab combination an impressive response was obtained.

CITATION  Clin Transl Oncol. 2007 Feb;9(2):119-20

you maybe interested

WHAT TECHNOLOGY
DO WE USE?

The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OUR
PROFESSIONALS

The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

Imagen profesionales de la Clínica Universidad de Navarra

WHY CHOOSE
THE CLINICA?

Learn why we are different from other healthcare centers. Quality, speed, comfort and results.

Imagen del edificio de la Clínica Universidad de Navarra